T-20: Began Phase III trial

Trimeris Inc. (TRMS), Durham, N.C. F. Hoffmann-La Roche Ltd. (SWX:ROCZ), Basel, Switzerland Product: T-20 Business: Infectious diseases Therapeutic category: Viral infection Target: HIV gp41 pepti...